APOE and Alzheimer disease: Accordingly, the aim of the present study is to investigate the prognostic value of baseline clinical data, ε4 allele of the apolipoprotein E (APOE) gene, and CSF biomarkers as determinants of mortality and institutionalization in persons diagnosed with AD.